Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 23, 2025-Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators f... [3225 chars].. reed more
